Insider Transactions in Q3 2025 at Lexeo Therapeutics, Inc. (LXEO)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 29
2025
|
Louis Edward Tamayo Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+50.0%
|
-
|
|
Aug 18
2025
|
Jose Manuel Otero Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
2,848
-4.5%
|
$11,392
$4.67 P/Share
|
|
Aug 18
2025
|
Richard Nolan Townsend Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,735
-1.23%
|
$10,940
$4.67 P/Share
|
|
Aug 18
2025
|
Eric Adler Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
608
-0.9%
|
$2,432
$4.67 P/Share
|
|
Aug 18
2025
|
Jenny Robertson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
542
-0.86%
|
$2,168
$4.67 P/Share
|
|
Aug 18
2025
|
Tai Sandi See Chief Development Officer |
SELL
Open market or private sale
|
Direct |
382
-0.64%
|
$1,528
$4.67 P/Share
|